Abstract
The acronym SMS (Stiff-Man Syndrome) identifies a syndrome of slowly progressive stiffness involving skeletal muscles (mainly axial) with superimposed muscle spasms. It was first described by Moersch and Woltmann in 1956 [1]. A set of diagnostic criteria was proposed by Gordon et al. [2] and Lorish et al. [3]. Diagnostic criteria included: 1) a prodrome of stiffness and rigidity in axial muscles; 2) a slow progression of stiffness involving proximal limb muscles, making walking difficult; 3) a fixed deformity, usually lordosis, of the spine; 4) the presence of superimposed muscle spasms, often precipitated by external stimuli; 5) normal motor and sensory nerve findings; 6) normal mental status and 7) an EMG finding of continuous motor unit activity (CMUA) at rest, abolished by intravenous diazepam or reduced by orally administered diazepam. It has been recently debated whether SMS is a single disease entity. Thirty-eight reported SMS patients were rexamined [4]; only seven of them (18.4%) fulfilled the Lorish diagnostic criteria [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Moersch FP, Woltmann HW (1956) Progressive fluctuating muscular rigidity and spasm (stiff-man syndrome): report of a case and some observations in 13 other cases. Mayo Clin Proc 31:421–427
Gordon EE, Januszko DM, Kaufman L (1967) A critical survey of stiff-man syndrome. Am J Med 42:582–599
Lorish TR, Thorsteinsson G, Howard FM (1989) Stiff-man syndrome updated. Mayo Clin Proc 64: 629–636
Piccolo G, Moglia A (1993) Stiff-man syndrome: one disease entity or more. In: Layzer RB, Sandrini G, Piccolo G, Martinelli M (eds) Motor Unit Hyperactivity States, Raven Press New York pp 23–30)
Brown P, Marsden CD (1999) The stiff man and stiff man plus syndrome. J Neurol 246:648–652
Howard FM Jr (1963) A new and effective drug in the treatment of stiff-man syndrome: preliminary report. Mayo Clin Proc 38:203–212
Cohen L (1966) Stiff-man syndrome: two patients treated with diazepam. JAMA 195:222–224
Westblom U (1977) Stiff-man syndrome and clonazepam. JAMA 237:1930
Spehlmann R, Norcross K, Rasmus SC, Schlageter NL (1981) Improvement of stiff-man syndrome with sodium valproate. Neurology 31:162–163
Meinck H-M, Conrad B (1986) Neuropharmacological investigations in the stiff-man syndrome. J Neurol 233:340–347
Boiardi A, Crenna P, Bussone G et al (1980) Neurological and pharmacological evaluation of a case of stiff-man syndrome. J Neurol 223:127–33
Henningsen P, Clement U, Kuchenhoff J et al (1996) Psychological factors in the diagnosis and pathogenesis of stiff-man syndrome. Neurology 47:38–42
Black JL, Barth EM, Williams DE, Tinsley JA (1998) Stiff-man syndrome. Results of interviews and psychologic testing. Psychosomatics 39:38–44
Tinsley JA, Barth EM, Black JL, Williams DE (1997) Psychiatric consuhations in stiffman syndrome. J Clin Psychiatry 58:444–449
Mitsumoto H, Schwartzman MJ, Estes ML et al (1991) Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J. Neurol 238:91–96
Floeter MK, Valls-Solè J, Toro C et al (1998) Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology 51:85–93
Levy LM, Dalakas MC, Floeter MK (1999) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 13:522–530
Solimena M, Folli F, Denis-Donini S et al (1988) Autoantibodies to glutamic acid decarboxilase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012–1020
Oertel WH, Schmechel DE, Mugnaini E et al (1981) Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum. Neuroscience 6:2715–2735
Mugnaini E, Oertel WH (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T (eds) Handbook of Chemical Neuroanatomy. Vol 4. GABA and neuropeptides in the CNS, Part I. Amsterdam, Elsevier Science Publishers, pp 436–608
Palay SL, Chan-Palay V (1974) Cerebellar cortex: cytology and organization. Springer-Verlag, New York
Kaufman DL, McGinnis JF, Krieger NR, Tobin AJ (1986) Brain glutamate decarboxilase-cloned in labda yt-U: fusion protein produces gamma-aminobutyric acid. Science 232:1138–1140
Erlander MG, Tillakatne NJK, Feldblum S et al (1991) Two genes encode distinct glutamate decarboxilases. Neuron 7:91–100
Pugliese A, Gianani R, Eisenbarth GS et al (1994) Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. Lancet 344:1027–8
Williams AC, Nutt JG, Hare T (1988) Autoimmunity in stiff-man syndrome. Lancet 2:222
Reetz A, Solimena M, Matteoli M et al (1991) G ABA and pancreatic ß-cells: colocalization of glutamic acid decarboxilase (GAD) and G AB A with synaptic-like microvescicles suggests their role in GABA storage and secretion. EMBO J 10:1275–1284
Vincent SR, Hokfelt T, Wu J-Y et al (1983) Immunohistochemical studies of the GABA system in the pancreas. Neuroendocrinology 36:197–204
Persson H, Pelto-Huikko M, Metsis M et al (1990) Expression of the neurotransmittersynthesizing enzyme glutamic acid decarboxilase in male germ cells. Mol Cell Biol 10:4701–4711
Erdo SL, Joo F, Wolff JR (1989) Immunohistochemical localization of glutamate decarboxilase in the rat oviduct and ovary: further evidence for non-neural GABA systems. Cell Tissue Res 255:431–434
Solimena M, Folli F, Aparisi R et al (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl I Med (1990) 322:1555–1560
Grimaldi LME, Martino G, Braghi S et al (1993) Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol 34:57–64
McEvoy KM (1991) Stiff-man syndrome. Seminars in Neurology 11:197–205
Toro C, Jacobowitz DM, Hallett M (1994) Stiff-man syndrome. Seminars in Neurology 14:154–158
Gorin F, Baldwin B, Tait R et al (1990) Stiff-man syndrome: a GABAergic autoimmune disorder with autoantigenic heterogeneity. Ann Neurol 28:71–74
Harding AE, Thompson PD, Kocen RS et al (1989) Plasma exchange and immunosup-pression in the stiff man syndrome. Lancet 2:915
Baekkeskov S, Aanstoot H-J, Christgau S et al (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxilase. Nature 347:151–156
Lernmark A (1996) Glutamic acid decarboxylase-gene to antigen to disease. J Intern Med 240:259–277
Saiz A, Arpa J, Sagasta A et al (1997) Autoantibodies to glutamic acid decarboxilase in three patients with cerebellar ataxia, late-onset insulin dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49:1026–1030
Nemni R, Braghi S, Natali-Sora MG et al (1994) Autoantibodies to glutamic acid decar-boxylase in palatal myoclonus and epilepsy. Ann Neurol 36:665–7
Folli F, Solimena M, Cofiell R et al (1993) Autoantibodies to a 128-kd protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med 328:546–551
Masson C, Prier S, Benoit C et al (1987) Amnésie, syndrome de V homme raide: Manifestations révélatrices d’une encéphalomyélite paranéoplastique. Ann Med Interne 138:502–505
Piccolo G, Cosi V, Zandrini C, Moglia A (1988) Steroid-responsive and dependent stiffman syndrome: a clinical and electrophysiological study of two cases. Ital J Neurol Sei 9:559–566
Piccolo G, Cosi V (1989) Stiff man syndrome, dysimmune disorder, and cancer. Ann Neurol 26:105
Bateman DE, Weller RO, Kennedy P (1990) Stiff man syndrome: a rare paraneoplastic disorder? J Neurol Neurosurg Psichiatry 53:695–696
Silverman IE (1999) Paraneoplastic stiff limb syndrome. J Neurol Neurosurg Psychiatry 67:126–7
Valldeoriola F (1999) Movement disorders of autoimmune origin. J Neurol 246:423–431
De CamilH P, Cameron R, Greengard P (1983) Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections, J Cell Biol 96:1337–1354
Navone F, Jahn R, Di Gioia G et al (1986) Protein p38: an integral membrane protein specific for small vescicles of neurons and neuroendocrine cells. J Cell Biol 103:2511–2527
De CamilH P, Thomas A, Cofiell R et al (1993) The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man Syndrome with breast cancer. J Exp Med 178:2219–2223
Dropcho EJ (1996) Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol 43:659–667
Saiz A, Dalmau J, Butler MH et al (1999) Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry 66:214–7
Antoine JC, Absi L, Honnorat J et al (1999) Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol 56:172–7
Martino G, Grimaldi LM, Bazzigaluppi E et al (1996) The insuHn-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients. J Neuro-immunol 69:129–134
Morgenthaler NG, Geissler J, Achenbach P et al (1997) Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Autoimmunity 25:203–211
Warich-Kirches M, Von Bossanyi P, Treuheit T et al (1997) Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clinical Neuropathology 16:214–219
Whiteley AM, Swash M, Urich H (1976) Progressive encephalomyelitis with rigidity. Its relation to “subacute myoclonic spinal neuronitis” and to the “stiff-man syndrome.” Brain 99:27–42
Leigh PN, Rothwell JC, Traub M, Marsden CD (1980) A patient with reflex myoclonus and muscle rigidity: jerking stiff-man syndrome. J. Neurol Neurosurg Psichiatry 43:1125–1131
Barker RA, Revesz T, Thom M et al (1998) Review of 23 patients affected by stiff-man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff-limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 65:633–640
Folli F (1998) Stiff man syndrome, 40 years later. J Neurol Neurosurg Psychiatry 65:618
Saiz A, Graus F, Valldeoriola F et al (1998) Stiff-leg syndrome: a focal form of stiff-man syndrome. Ann Neurol 43:400–401
Shaw PJ (1999) Stiff-man syndrome and its variants. Lancet 353:86–87
Liguori R, Medori R, Marcello L et al (1993) Vigabatrin improves rigidity in stiff-person syndrome (SPS). Neurology 43:311
IA Sharoqi (1998) Improvement of stiff-man syndrome with vigabatrin. Neurology 50:833–834
Stayer C, Tronnier V, Dressnandt J et al (1997) Intrathecal baclofen therapy for stiffman syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology 49:1591–1597
Liguori L, Cordivari C, Lugaresi E, Montagna P (1997) Botulinum Toxin A improves muscle spasms and rigidity in Stiff-person syndrome. Movement Disorders 12:1060–1063
Shmierer K, Valduzca IM, Bender A et al (1998) Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology 51:250–252
McCombe PA, Chalk JB, Searle IW et al (1989) Progressive encephalomyelitis with rigidity: a case report with magnetic resonance imaging findings. I Neurol Neurosurg Psychiatry 52:1429–1431
Barker RA, Marsden CD (1997) Successful treatment of stiff-man syndrome with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 62:426–7
Amato AA, Cornman EW, Kissel JT (1994) Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology 44:1652–1660
Vicari AM, Folli F, Pozza G et al (1989) Plasmapheresis in the treatment of Stiff-Man Syndrome. N Engl] Med 320:1499
Hummel M, Durinovic-Bello I, Bonifacio E et al (1998) Humoral and cellular immune parameters before and after immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. I Neurol Neurosurgery and Psychiatry 65:204–208
Hao W, Davis C, Hirsch IB et al (1999) Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study. J Neurol 246:731–735
Brashear HR, Phillips LH (1991) Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 41:1588–1592
Anonimous (1996) Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 47:840–843
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Italia
About this chapter
Cite this chapter
Folli, F., Piccolo, G. (2002). Stiff-Man Syndrome: Pathogenetic, Nosological and Therapeutic Considerations. In: Vincent, A., Martino, G. (eds) Autoantibodies in Neurological Diseases. Topics in Neuroscience. Springer, Milano. https://doi.org/10.1007/978-88-470-2097-9_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-2097-9_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2163-1
Online ISBN: 978-88-470-2097-9
eBook Packages: Springer Book Archive